Grant: Discovery Grants Program - Individual
University of Guelph
$37,000.00
Complex carbohydrates: structure, function and vaccines
FY 2007-08
Summary
Carbohydrates are a major component of bacteria, plants and mammalian cells. Our research program focuses on the fine structural characterization and functional role of such complex carbohydrates, and in the use of these organism-specific carbohydrates in drug and vaccine preparations. The majority of our attention is directed at deciphering the complex polysaccharide structures expressed by infectious bacteria by using chemical methods and analytical techniques, such as, mass-spectrometry and nuclear magnetic resonance spectroscopy. We are interested in pursuing the study of medically important bacteria, for example, the recently discovered Alloiococcus otitidis, which is responsible for middle-ear infections in humans. We are also engaged in studying the chemical structures and immunochemical properties of metabolites and polysaccharides from health-related plants, such as, St. John's Wort, and of mammalian cells involved in embryogenesis. It is now well accepted that polysaccharides are capable of eliciting the immune system to raise polysaccharide-specific antibodies and in enhancing the immune systems' defensive mechanism as a whole. Hence, one of our ultimate research objectives is aimed at employing these novel structurally-defined carbohydrates as protective antigens in prophylactic glycoconjugate vaccines and therapeutic drugs.
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
283115-2007
Name nom
Monteiro, Mario
Department département
Chemistry
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2007
Competition year année de concours
2007
Award amount
37000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
24
Committee name en
Inorganic & Organic Chemistry
Committee name fr
Chimie inorg. et org.
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
3702
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Carbohydrates
Research subject fr
Glucides
Partie
1
Nb partie
3
Application title
Complex carbohydrates: structure, function and vaccines
Keyword
NA
Application summary
Carbohydrates are a major component of bacteria, plants and mammalian cells. Our research program focuses on the fine structural characterization and functional role of such complex carbohydrates, and in the use of these organism-specific carbohydrates in drug and vaccine preparations. The majority of our attention is directed at deciphering the complex polysaccharide structures expressed by infectious bacteria by using chemical methods and analytical techniques, such as, mass-spectrometry and nuclear magnetic resonance spectroscopy. We are interested in pursuing the study of medically important bacteria, for example, the recently discovered Alloiococcus otitidis, which is responsible for middle-ear infections in humans. We are also engaged in studying the chemical structures and immunochemical properties of metabolites and polysaccharides from health-related plants, such as, St. John's Wort, and of mammalian cells involved in embryogenesis. It is now well accepted that polysaccharides are capable of eliciting the immune system to raise polysaccharide-specific antibodies and in enhancing the immune systems' defensive mechanism as a whole. Hence, one of our ultimate research objectives is aimed at employing these novel structurally-defined carbohydrates as protective antigens in prophylactic glycoconjugate vaccines and therapeutic drugs.